Logo image
Se connecter
Two-Year Efficacy and Safety of Benralizumab for the Treatment of Eosinophilic Granulomatosis with Polyangiitis
Article de revue   Avec comité de lecture

Two-Year Efficacy and Safety of Benralizumab for the Treatment of Eosinophilic Granulomatosis with Polyangiitis

Michael Wechsler, Parameswaran Nair, Nader Khalidi, Benjamin Terrier, Bernhard Hellmich, Arnaud Bourdin, David Jayne, David Jackson, Florence Roufosse, Christian Pagnoux, …
Journal of allergy and clinical immunology, Vol.155(2), pp.AB430-AB430
02/2025

Indicateurs

1 Consultations de la notice

Détails

Logo image